GPT meets PubMed: a novel approach to literature review using a large language model to crowdsource migraine medication reviews

To evaluate the potential of two large language models (LLMs), GPT-4 (OpenAI) and PaLM2 (Google), in automating migraine literature analysis by conducting sentiment analysis of migraine medications in clinical trial abstracts. Migraine affects over one billion individuals worldwide, significantly im...

Full description

Saved in:
Bibliographic Details
Published inBMC neurology Vol. 25; no. 1; pp. 69 - 8
Main Authors Mackenzie, Elyse, Cheng, Roger, Zhang, Pengfei
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 19.02.2025
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To evaluate the potential of two large language models (LLMs), GPT-4 (OpenAI) and PaLM2 (Google), in automating migraine literature analysis by conducting sentiment analysis of migraine medications in clinical trial abstracts. Migraine affects over one billion individuals worldwide, significantly impacting their quality of life. A vast amount of scientific literature on novel migraine therapeutics continues to emerge, but an efficient method by which to perform ongoing analysis and integration of this information poses a challenge. "Sentiment analysis" is a data science technique used to ascertain whether a text has positive, negative, or neutral emotional tone. Migraine medication names were extracted from lists of licensed biological products from the FDA, and relevant abstracts were identified using the MeSH term "migraine disorders" on PubMed and filtered for clinical trials. Standardized prompts were provided to the APIs of both GPT-4 and PaLM2 to request an article sentiment as to the efficacy of each medication found in the abstract text. The resulting sentiment outputs were classified using both a binary and a distribution-based model to determine the efficacy of a given medication. In both the binary and distribution-based models, the most favorable migraine medications identified by GPT-4 and PaLM2 aligned with evidence-based guidelines for migraine treatment. LLMs have potential as complementary tools in migraine literature analysis. Despite some inconsistencies in output and methodological limitations, the results highlight the utility of LLMs in enhancing the efficiency of literature review through sentiment analysis.
AbstractList To evaluate the potential of two large language models (LLMs), GPT-4 (OpenAI) and PaLM2 (Google), in automating migraine literature analysis by conducting sentiment analysis of migraine medications in clinical trial abstracts. Migraine affects over one billion individuals worldwide, significantly impacting their quality of life. A vast amount of scientific literature on novel migraine therapeutics continues to emerge, but an efficient method by which to perform ongoing analysis and integration of this information poses a challenge. "Sentiment analysis" is a data science technique used to ascertain whether a text has positive, negative, or neutral emotional tone. Migraine medication names were extracted from lists of licensed biological products from the FDA, and relevant abstracts were identified using the MeSH term "migraine disorders" on PubMed and filtered for clinical trials. Standardized prompts were provided to the APIs of both GPT-4 and PaLM2 to request an article sentiment as to the efficacy of each medication found in the abstract text. The resulting sentiment outputs were classified using both a binary and a distribution-based model to determine the efficacy of a given medication. In both the binary and distribution-based models, the most favorable migraine medications identified by GPT-4 and PaLM2 aligned with evidence-based guidelines for migraine treatment. LLMs have potential as complementary tools in migraine literature analysis. Despite some inconsistencies in output and methodological limitations, the results highlight the utility of LLMs in enhancing the efficiency of literature review through sentiment analysis.
Abstract Objective To evaluate the potential of two large language models (LLMs), GPT-4 (OpenAI) and PaLM2 (Google), in automating migraine literature analysis by conducting sentiment analysis of migraine medications in clinical trial abstracts. Background Migraine affects over one billion individuals worldwide, significantly impacting their quality of life. A vast amount of scientific literature on novel migraine therapeutics continues to emerge, but an efficient method by which to perform ongoing analysis and integration of this information poses a challenge. Methods “Sentiment analysis” is a data science technique used to ascertain whether a text has positive, negative, or neutral emotional tone. Migraine medication names were extracted from lists of licensed biological products from the FDA, and relevant abstracts were identified using the MeSH term “migraine disorders” on PubMed and filtered for clinical trials. Standardized prompts were provided to the APIs of both GPT-4 and PaLM2 to request an article sentiment as to the efficacy of each medication found in the abstract text. The resulting sentiment outputs were classified using both a binary and a distribution-based model to determine the efficacy of a given medication. Results In both the binary and distribution-based models, the most favorable migraine medications identified by GPT-4 and PaLM2 aligned with evidence-based guidelines for migraine treatment. Conclusions LLMs have potential as complementary tools in migraine literature analysis. Despite some inconsistencies in output and methodological limitations, the results highlight the utility of LLMs in enhancing the efficiency of literature review through sentiment analysis.
ObjectiveTo evaluate the potential of two large language models (LLMs), GPT-4 (OpenAI) and PaLM2 (Google), in automating migraine literature analysis by conducting sentiment analysis of migraine medications in clinical trial abstracts.BackgroundMigraine affects over one billion individuals worldwide, significantly impacting their quality of life. A vast amount of scientific literature on novel migraine therapeutics continues to emerge, but an efficient method by which to perform ongoing analysis and integration of this information poses a challenge.Methods“Sentiment analysis” is a data science technique used to ascertain whether a text has positive, negative, or neutral emotional tone. Migraine medication names were extracted from lists of licensed biological products from the FDA, and relevant abstracts were identified using the MeSH term “migraine disorders” on PubMed and filtered for clinical trials. Standardized prompts were provided to the APIs of both GPT-4 and PaLM2 to request an article sentiment as to the efficacy of each medication found in the abstract text. The resulting sentiment outputs were classified using both a binary and a distribution-based model to determine the efficacy of a given medication.ResultsIn both the binary and distribution-based models, the most favorable migraine medications identified by GPT-4 and PaLM2 aligned with evidence-based guidelines for migraine treatment.ConclusionsLLMs have potential as complementary tools in migraine literature analysis. Despite some inconsistencies in output and methodological limitations, the results highlight the utility of LLMs in enhancing the efficiency of literature review through sentiment analysis.
To evaluate the potential of two large language models (LLMs), GPT-4 (OpenAI) and PaLM2 (Google), in automating migraine literature analysis by conducting sentiment analysis of migraine medications in clinical trial abstracts. Migraine affects over one billion individuals worldwide, significantly impacting their quality of life. A vast amount of scientific literature on novel migraine therapeutics continues to emerge, but an efficient method by which to perform ongoing analysis and integration of this information poses a challenge. "Sentiment analysis" is a data science technique used to ascertain whether a text has positive, negative, or neutral emotional tone. Migraine medication names were extracted from lists of licensed biological products from the FDA, and relevant abstracts were identified using the MeSH term "migraine disorders" on PubMed and filtered for clinical trials. Standardized prompts were provided to the APIs of both GPT-4 and PaLM2 to request an article sentiment as to the efficacy of each medication found in the abstract text. The resulting sentiment outputs were classified using both a binary and a distribution-based model to determine the efficacy of a given medication. In both the binary and distribution-based models, the most favorable migraine medications identified by GPT-4 and PaLM2 aligned with evidence-based guidelines for migraine treatment. LLMs have potential as complementary tools in migraine literature analysis. Despite some inconsistencies in output and methodological limitations, the results highlight the utility of LLMs in enhancing the efficiency of literature review through sentiment analysis.
To evaluate the potential of two large language models (LLMs), GPT-4 (OpenAI) and PaLM2 (Google), in automating migraine literature analysis by conducting sentiment analysis of migraine medications in clinical trial abstracts.OBJECTIVETo evaluate the potential of two large language models (LLMs), GPT-4 (OpenAI) and PaLM2 (Google), in automating migraine literature analysis by conducting sentiment analysis of migraine medications in clinical trial abstracts.Migraine affects over one billion individuals worldwide, significantly impacting their quality of life. A vast amount of scientific literature on novel migraine therapeutics continues to emerge, but an efficient method by which to perform ongoing analysis and integration of this information poses a challenge.BACKGROUNDMigraine affects over one billion individuals worldwide, significantly impacting their quality of life. A vast amount of scientific literature on novel migraine therapeutics continues to emerge, but an efficient method by which to perform ongoing analysis and integration of this information poses a challenge."Sentiment analysis" is a data science technique used to ascertain whether a text has positive, negative, or neutral emotional tone. Migraine medication names were extracted from lists of licensed biological products from the FDA, and relevant abstracts were identified using the MeSH term "migraine disorders" on PubMed and filtered for clinical trials. Standardized prompts were provided to the APIs of both GPT-4 and PaLM2 to request an article sentiment as to the efficacy of each medication found in the abstract text. The resulting sentiment outputs were classified using both a binary and a distribution-based model to determine the efficacy of a given medication.METHODS"Sentiment analysis" is a data science technique used to ascertain whether a text has positive, negative, or neutral emotional tone. Migraine medication names were extracted from lists of licensed biological products from the FDA, and relevant abstracts were identified using the MeSH term "migraine disorders" on PubMed and filtered for clinical trials. Standardized prompts were provided to the APIs of both GPT-4 and PaLM2 to request an article sentiment as to the efficacy of each medication found in the abstract text. The resulting sentiment outputs were classified using both a binary and a distribution-based model to determine the efficacy of a given medication.In both the binary and distribution-based models, the most favorable migraine medications identified by GPT-4 and PaLM2 aligned with evidence-based guidelines for migraine treatment.RESULTSIn both the binary and distribution-based models, the most favorable migraine medications identified by GPT-4 and PaLM2 aligned with evidence-based guidelines for migraine treatment.LLMs have potential as complementary tools in migraine literature analysis. Despite some inconsistencies in output and methodological limitations, the results highlight the utility of LLMs in enhancing the efficiency of literature review through sentiment analysis.CONCLUSIONSLLMs have potential as complementary tools in migraine literature analysis. Despite some inconsistencies in output and methodological limitations, the results highlight the utility of LLMs in enhancing the efficiency of literature review through sentiment analysis.
Objective To evaluate the potential of two large language models (LLMs), GPT-4 (OpenAI) and PaLM2 (Google), in automating migraine literature analysis by conducting sentiment analysis of migraine medications in clinical trial abstracts. Background Migraine affects over one billion individuals worldwide, significantly impacting their quality of life. A vast amount of scientific literature on novel migraine therapeutics continues to emerge, but an efficient method by which to perform ongoing analysis and integration of this information poses a challenge. Methods "Sentiment analysis" is a data science technique used to ascertain whether a text has positive, negative, or neutral emotional tone. Migraine medication names were extracted from lists of licensed biological products from the FDA, and relevant abstracts were identified using the MeSH term "migraine disorders" on PubMed and filtered for clinical trials. Standardized prompts were provided to the APIs of both GPT-4 and PaLM2 to request an article sentiment as to the efficacy of each medication found in the abstract text. The resulting sentiment outputs were classified using both a binary and a distribution-based model to determine the efficacy of a given medication. Results In both the binary and distribution-based models, the most favorable migraine medications identified by GPT-4 and PaLM2 aligned with evidence-based guidelines for migraine treatment. Conclusions LLMs have potential as complementary tools in migraine literature analysis. Despite some inconsistencies in output and methodological limitations, the results highlight the utility of LLMs in enhancing the efficiency of literature review through sentiment analysis. Keywords: Headaches, Large language model, Artificial intelligence, Literature review, Migraine
ArticleNumber 69
Audience Academic
Author Mackenzie, Elyse
Cheng, Roger
Zhang, Pengfei
Author_xml – sequence: 1
  givenname: Elyse
  surname: Mackenzie
  fullname: Mackenzie, Elyse
– sequence: 2
  givenname: Roger
  surname: Cheng
  fullname: Cheng, Roger
– sequence: 3
  givenname: Pengfei
  surname: Zhang
  fullname: Zhang, Pengfei
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39972406$$D View this record in MEDLINE/PubMed
BookMark eNptkk1v1DAQhiNURD_gD3BAkbj0kuKvxA4XVFVQKhXRQzlbjjNOvcrai51sxYm_zuwHVRehSMlo8sw7nvF7WhyFGKAo3lJyQalqPmTKlOIVYXVFBJG0oi-KEyowYFzKo2fxcXGa84IQKpWgr4pj3raSCdKcFL-v7-7LJcCUy7u5-wb9x9KUIa5hLM1qlaKxD-UUy9FPkMw0JygTrD08lnP2YUB2NGkAfIdhNhgsY4-lWGFTfOxznJPFpB-S8QED6L01k49hL5NfFy-dGTO82X_Pih9fPt9ffa1uv1_fXF3eVram9VQx2beiF6AkY9Q1TPUtFaIFCdDX1jFjOiI6MMh0plOdFU4qWVPriAXpDD8rbna6fTQLvUp-adIvHY3X20RMgzZp8nYErRwI7IN9OYhOSeUUa4C4mnIrnRWo9WmntZo7nMhCmJIZD0QP_wT_oIe41nhrXHJFUOF8r5DizxnypJc-WxhxjRDnrDltlJSENhLR9_-gC1xqwF0hJWtBaLsV3FODwQl8cBEb242ovlRMUbSH2Bz84j8UPj0svUVzOY_5g4J3zyd9GvGvfxBgOwCvO-cE7gmhZDNuo3cm1WhSvTWppvwP8EvZ2g
Cites_doi 10.1177/03331024231157379
10.1186/s10194-019-0974-3
10.3389/fneur.2021.800605
10.1007/s12195-023-00761-3
10.3389/fdgth.2022.878369
10.1212/WNL.0000000000207967
10.1111/head.14495
10.2196/16023
10.1111/head.14153
ContentType Journal Article
Copyright 2025. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2025 2025
Copyright_xml – notice: 2025. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
– notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2025 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12883-025-04071-1
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central Database Suite (ProQuest)
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database (ProQuest)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

Publicly Available Content Database
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals (DOAJ)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2377
EndPage 8
ExternalDocumentID oai_doaj_org_article_8fe48725153e4b878f826e0f513c7fc4
PMC11837380
A828140744
39972406
10_1186_s12883_025_04071_1
Genre Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABIVO
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ITC
KQ8
M1P
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7TK
7XB
8FK
AZQEC
DWQXO
K9.
M48
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c515t-27d94d4e87221f628d91449e7eed5cf2aab04bea4d4bab8bc4f78751cf0ce7fa3
IEDL.DBID 7X7
ISSN 1471-2377
IngestDate Wed Aug 27 01:27:19 EDT 2025
Thu Aug 21 18:28:40 EDT 2025
Thu Jul 10 19:02:36 EDT 2025
Fri Jul 25 21:28:36 EDT 2025
Tue Jun 17 21:59:09 EDT 2025
Tue Jun 10 20:58:46 EDT 2025
Mon Jul 21 06:07:03 EDT 2025
Tue Aug 05 11:58:06 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Headaches
Literature review
Large language model
Artificial intelligence
Migraine
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c515t-27d94d4e87221f628d91449e7eed5cf2aab04bea4d4bab8bc4f78751cf0ce7fa3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/3175401980?pq-origsite=%requestingapplication%
PMID 39972406
PQID 3175401980
PQPubID 44772
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_8fe48725153e4b878f826e0f513c7fc4
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11837380
proquest_miscellaneous_3168770167
proquest_journals_3175401980
gale_infotracmisc_A828140744
gale_infotracacademiconefile_A828140744
pubmed_primary_39972406
crossref_primary_10_1186_s12883_025_04071_1
PublicationCentury 2000
PublicationDate 2025-02-19
PublicationDateYYYYMMDD 2025-02-19
PublicationDate_xml – month: 02
  year: 2025
  text: 2025-02-19
  day: 19
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC neurology
PublicationTitleAlternate BMC Neurol
PublicationYear 2025
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 4071_CR9
P Amiri (4071_CR1) 2022; 12
MR King (4071_CR15) 2023; 16
F Cohen (4071_CR6) 2023; 63
A Zunic (4071_CR8) 2020; 8
J Ailani (4071_CR14) 2021; 61
KP Peng (4071_CR5) 2023; 43
MF Romano (4071_CR7) 2023; 101
Y Guo (4071_CR13) 2023; 2023
4071_CR12
4071_CR11
4071_CR3
4071_CR10
TP Do (4071_CR2) 2019; 20
4071_CR4
References_xml – ident: 4071_CR4
– ident: 4071_CR3
– volume: 43
  start-page: 033310242311573
  issue: 4
  year: 2023
  ident: 4071_CR5
  publication-title: Cephalalgia
  doi: 10.1177/03331024231157379
– volume: 20
  start-page: 37
  issue: 1
  year: 2019
  ident: 4071_CR2
  publication-title: J Headache Pain
  doi: 10.1186/s10194-019-0974-3
– volume: 12
  year: 2022
  ident: 4071_CR1
  publication-title: Front Neurol
  doi: 10.3389/fneur.2021.800605
– volume: 16
  start-page: 175
  issue: 2
  year: 2023
  ident: 4071_CR15
  publication-title: Cel Mol Bioeng
  doi: 10.1007/s12195-023-00761-3
– ident: 4071_CR9
  doi: 10.3389/fdgth.2022.878369
– volume: 101
  start-page: 1058
  issue: 23
  year: 2023
  ident: 4071_CR7
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000207967
– volume: 63
  start-page: 694
  issue: 5
  year: 2023
  ident: 4071_CR6
  publication-title: Headache
  doi: 10.1111/head.14495
– volume: 8
  issue: 1
  year: 2020
  ident: 4071_CR8
  publication-title: JMIR Med Inform
  doi: 10.2196/16023
– ident: 4071_CR11
– ident: 4071_CR12
– ident: 4071_CR10
– volume: 61
  start-page: 1021
  issue: 7
  year: 2021
  ident: 4071_CR14
  publication-title: Headache.
  doi: 10.1111/head.14153
– volume: 2023
  start-page: 261
  year: 2023
  ident: 4071_CR13
  publication-title: AMIA Jt Summits Transl Sci Proc
SSID ssj0017841
Score 2.3879611
Snippet To evaluate the potential of two large language models (LLMs), GPT-4 (OpenAI) and PaLM2 (Google), in automating migraine literature analysis by conducting...
Objective To evaluate the potential of two large language models (LLMs), GPT-4 (OpenAI) and PaLM2 (Google), in automating migraine literature analysis by...
ObjectiveTo evaluate the potential of two large language models (LLMs), GPT-4 (OpenAI) and PaLM2 (Google), in automating migraine literature analysis by...
Abstract Objective To evaluate the potential of two large language models (LLMs), GPT-4 (OpenAI) and PaLM2 (Google), in automating migraine literature analysis...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 69
SubjectTerms Analysis
Application programming interface
Artificial intelligence
Biological products
Bupivacaine
Clinical trials
Crowdsourcing
Crowdsourcing - methods
Drug therapy
Drugs
Evidence-based medicine
FDA approval
Headache
Headaches
Homeopathy
Humans
Large language model
Large Language Models
Levetiracetam
Literature review
Literature reviews
Materia medica and therapeutics
Medical Subject Headings-MeSH
Migraine
Migraine Disorders - drug therapy
Monoclonal antibodies
Pharmaceuticals
PubMed
Python
Quality of life
Sentiment analysis
Technology application
Therapeutics
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYqDlUvVVtom5ZWRkLiUFnk4SR2b4AKCAnEASRuVmyPKdKSRd0sHPvXO-Mkq4164MJtFU9W8TwyM_HMN4zt-jRzIL0VFXgnJFRONOj5RA5BVRQB-4hbcH5RnV7Ls5vyZm3UF9WE9fDAPeP2VQCMqdELlwVIq2oVMCCGNJRZ4ergIhIo-rwxmRrOD-g0bWyRUdX-IqOhuoJGt6aUwYhs4oYiWv__7-Q1pzQtmFzzQMfv2NshdOQH_SO_Z6-g_cBenw-H45vs78nlFb8H6Bb8cmnx-k_e8Hb-CDM-Iofzbs5nKyBl3vetcKp9v0XaGVWF8_ELJo9DcugO3MKT77_y8_u7WxoqgT_iCQ-JdfibxRa7Pv51dXQqhvkKwiE7O5HXXksvAdmbZ6HKldeYXmmo0W-WLuRNY1NpoUEa21hlnQxo3mXmQuqgDk3xkW208xY-M46uFgM1sFpBIUMZtAatvHVae-kD5An7MbLbPPQwGiamH6oyvXAMCsdE4ZgsYYckkRUlQWDHC6gYZlAM85xiJGyP5GnIUFForhn6DfCBCfLKHGCuidllLZFye0KJBuamy6NGmMHAF4bCLkxNtUoTtrNapjupaK2F-ZJoKlXX1OeRsE-9Aq22VFDDMgZTCVMT1ZrsebrS3v2O8N_INIKjSr-8BJe-sjd5NItcZHqbbXR_lvANw6zOfo8W9Q83ISbR
  priority: 102
  providerName: Directory of Open Access Journals
Title GPT meets PubMed: a novel approach to literature review using a large language model to crowdsource migraine medication reviews
URI https://www.ncbi.nlm.nih.gov/pubmed/39972406
https://www.proquest.com/docview/3175401980
https://www.proquest.com/docview/3168770167
https://pubmed.ncbi.nlm.nih.gov/PMC11837380
https://doaj.org/article/8fe48725153e4b878f826e0f513c7fc4
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdbC2MvY9_z1gUNBnsYov6QbWkvoxntyqAllBbCXoQtndJCandNsj3uX9-dbGc1g70EY52D5dPpPnT3O8beuzixIF0tCnBWSCisqFDziRS8KsgCdgG34OS0OL6Q3-b5vA-4rfq0ymFPDBu1ay3FyPdJz6EvoFX8-eaHoK5RdLrat9C4z3YJuoxSusr51uFK6ExtKJRRxf4qoda6ghq4xuTHiGSkjAJm_7878x3VNE6bvKOHjh6zR70ByQ86jj9h96B5yh6c9Efkz9jvr7Nzfg2wXvHZpsb7n3jFm_YnLPmAH87XLV9u4ZR5V73CKQN-gbRLyg3nQxyTh1Y59ARO4ZfrYv38-mpBrSXwIpzzEHP7v1k9ZxdHh-dfjkXfZUFYtGXWIi2dlk6CKtM08UWqnEYnS0OJ2jO3Pq2qOpY1VEhTV7WqrfQo5HlifWyh9FX2gu00bQOvGEeFi-Ya1FpBJn3utQatXG21dtJ5SCP2cfjc5qYD0zDBCVGF6ZhjkDkmMMckEZsSR7aUBIQdbrS3C9PLlVEe0OVCIy3PQNaqVB79JYh9nmS29FZG7APx05C4ItNs1Vcd4AsT8JU5QI8TfcxSIuXeiBLFzI6HhxVhejFfmb-LMmLvtsP0JKWuNdBuiKZQZUnVHhF72S2g7ZQyKltGkypiarS0RnMejzRXlwEEHD8agVLFr___Xm_YwzQs-FQkeo_trG838BbNqHU9CbIyYbvTw9PZ2SQEI_D3bPr9D4N4ImQ
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVgIuiDeBAkYCcUBR83ASGwmhFlq2tLtaoVbqzST2eKm0TUp3l4oT_4jfyEweSyMkbr1F8SSKM2PPfJ4XYy9tEBoQtvBTsMYXkBo_R83nR-BkShawresWjMbp8Eh8Pk6O19jvLheGwiq7PbHeqG1l6Ix8k_QcYgElg_dn333qGkXe1a6FRiMW-_DzAiHb_N3eR-Tvqyja3Tn8MPTbrgK-Qd298KPMKmEFyCyKQpdG0ioEFQoy1BaJcVGeF4EoIEeaIi9kYYRDoU5C4wIDmctjfO81ti5ihDIDtr69M558WfktyIvXpebIdHMeUjNfn1rGBoSc_LCn_uouAf_qgkvKsB-oeUnz7d5mt1qTlW81MnaHrUF5l10ftU75e-zXp8khPwVYzPlkWeD9tzznZfUDZryrWM4XFZ-tCjjzJl-GU8z9FGlnFI3Ou5NTXjfnoSdwChe28S7w05MpNbPAi9qzROLUvmZ-nx1dCQcesEFZlfCIcVTxaCBCoSTEwiVOKVDSFkYpK6yDyGNvut-tz5ryHbqGPTLVDXM0MkfXzNGhx7aJIytKKr1d36jOp7pdyVo6QJCHZmESgyhkJh0iNAhcEsYmc0Z47DXxU9MGgUwzeZvngB9Mpbb0FmJcRLWZQMqNHiUubNMf7iRCtxvLXP9dBh57sRqmJylYroRqSTSpzDLKL_HYw0aAVlOKKVEajTiPyZ5o9ebcHylPvtVlx_GnURms4PH_v-s5uzE8HB3og73x_hN2M6qFP_JDtcEGi_MlPEUjblE8a1cOZ1-verH-AY4XXxk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=GPT+meets+PubMed%3A+a+novel+approach+to+literature+review+using+a+large+language+model+to+crowdsource+migraine+medication+reviews&rft.jtitle=BMC+neurology&rft.au=Mackenzie%2C+Elyse&rft.au=Cheng%2C+Roger&rft.au=Zhang%2C+Pengfei&rft.date=2025-02-19&rft.pub=BioMed+Central&rft.eissn=1471-2377&rft.volume=25&rft_id=info:doi/10.1186%2Fs12883-025-04071-1&rft.externalDocID=PMC11837380
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2377&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2377&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2377&client=summon